Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer

Acta Radiologica

Volumn 52, Issue 1, 2011, Pages 120-126

  Nishida, Kaori ^a   Yuen, Sachiko ^a   Kamoi, Kazumi ^a   Yamada, Kei ^a   Akazawa, Kentaro ^a   Ito, Hirotoshi ^b   Okihara, Koji ^a   Kawauchi, Akihiro ^a   Miki, Tsuneharu ^a   Nishimura, Tsunehiko ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Kajiicho Medical Imaging Center   (Japan)

Author keywords

Adults; Autcomes analysis; MRI; Neoplasm primary; Prostate; Urinary

Indexed keywords

ADULTS; AUTCOMES ANALYSIS; NEOPLASM-PRIMARY; PROSTATE; URINARY;

FORECASTING; MAGNETIC RESONANCE IMAGING; MULTIVARIANT ANALYSIS; UROLOGY;

DISEASES;

AGED; ARTICLE; DIFFUSION WEIGHTED IMAGING; EVALUATION; HUMAN; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOLOGY; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PROSTATE; PROSTATE TUMOR; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 79960092666     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2010.100293     Document Type: Review

References (35)

1. Han M, Partin AW, Zahurak M, et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169:517-23 (Pubitemid 36132976)
2. Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90:766-71 (Pubitemid 28259189)
3. Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006;98:715-7 (Pubitemid 43821789)
4. Heenan SD. Magnetic resonance imaging in prostate cancer. Prostate Cancer Prostatic Dis 2004;7:282-8 (Pubitemid 41721784)
5. Qayyum A, Coakley FV, Lu Y, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. Am J Roentgenol 2004;183:1079-83 (Pubitemid 44185100)
6. Shukla-Dave A, Hricak H, Eberhardt SC, et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings-initial observations. Radiology 2004;231:717-24 (Pubitemid 38668088)
7. Choi YJ, Kim JK, Kim N, et al. Functional MR imaging of prostate cancer. Radiographics 2007;27:63-75
8. Kim JK, Hong SS, Choi YJ, et al. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging 2005;22:639-46 (Pubitemid 41572716)
9. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002;16:196-200 (Pubitemid 34810058)
10. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 2004;20:654-61 (Pubitemid 39313742)
11. Pickles MD, Gibbs P, Sreenivas M, et al. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0 T. J Magn Reson Imaging 2006;23:130-4 (Pubitemid 43191065)
12. Gibbs P, Pickles MD, Turnbull LW. Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol 2006;41:185-8 (Pubitemid 44406217)
13. Kozlowski P, Chang SD, Jones EC, et al. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 2006;24:108-13
14. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 2008;28:720-6
15. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005;21:258-62 (Pubitemid 40280120)
16. Kim CK, Park BK, Lee HM, et al. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol 2007;42:842-7 (Pubitemid 350126566)
17. Chan I, Wells W 3rd Mulkern RV, et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging;a multichannel statistical classifier. Med Phys 2003;30:2390-8 (Pubitemid 37129745)
18. Lim HK, Kim JK, Kim KA, et al. Prostate Cancer: Apparent Diffusion Coefficient Map With T2-Weighted Images for Detection - A Multireader Study. Radiology 2009;250:145-51
19. Haider MA, van der Kwast TH, Tanguay J, et al. Combind T2-weighted and diffusion-weighted MRI for localization of prostate cancer. Am J Roentgenol 2007;189:323-8 (Pubitemid 47195916)
20. D'Amico AV, Whittington R, Malkowicz B, et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 2000;164:759-63 (Pubitemid 30637618)
21. Manzone TA, Malkowicz SB, Tomaszewski JE, et al. Use of endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomy. Radiology 1998;209:537-42 (Pubitemid 28503126)
22. Cheng GC, Chen MH, Whittington R, et al. Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA, or = 10, and clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2003;55:64-70 (Pubitemid 36020344)
23. Fuchsjäger MH, Shukla-Dave A, Hricak H, et al. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy. BJU Int 2009;104:315-20
24. Poulakis V, Witzsch U, de Vries R, et al. Preoperative neural network using combined magnetic resonance imaging variables, prostatespecific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy. Urology 2004;64:1165-70 (Pubitemid 39647060)
25. Shukla-Dave A, Hricak H, Ishill N, et al. Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles. Clin Cancer Res 2009;15:3842-9
26. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195:385-90
27. Walsh PC. Radical retropubic prostatectomy. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED eds. Campbefls Textbook of Urology. Philadelphia, PA: WB Saunders 1992:2865-86
28. Cookson MS, Aus G, Burnett AL, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007;177:540-5 (Pubitemid 46054056)
29. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006;239:784-92 (Pubitemid 43830614)
30. Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005;29:149-53 (Pubitemid 40411296)
31. Greene FL. Prostate. In: Greene FL, Page DL, Fleming ID, et al. eds. AJCC Cancer Staging Manual. 6th edn. New York, NY: Springer-Verlag 2002:309-16
32. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999;213:481-8 (Pubitemid 29510596)
33. Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristic rating analysis: Generalization to the population of readers and patients with the jackknife method. Investigative Radiology 1992;27:723-31
34. Gibbs P, Liney GP, Pickles MD, et al. Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla. Investigative Radiology 2009;44:572-6
35. Wang XZ, Wang B, Gao ZQ, et al. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging 2009;29:1360-6